Green Life Science Co Ltd
114450
Company Profile
Business description
Green Life Science Co Ltd Formerly KPX Lifescience Co Ltd manufactures and markets active pharmaceutical ingredients and pharmaceutical intermediates. The company exports all its products to global pharmaceutical firms exclusively. Its products include Dexibuprofen, Quetiapine hemifumarate, Venlafaxine free base and Triazolinone among others.
Contact
84, Yeosusandan 2-ro
Jeollanam-do
Yeosu-si555-280
KORT: +82 616814600
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
65
Stocks News & Analysis
stocks
Overvalued ASX share as market underestimates downside risks
Growth outlook solid, but upside more than priced in.
stocks
New production imminent for undervalued ASX gas play
LNG project receives first commissioning gas.
stocks
Going into earnings, is Tesla stock a buy, a sell, or fairly valued?
Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,324.60 | 40.80 | 0.44% |
| CAC 40 | 8,206.07 | 31.87 | 0.39% |
| DAX 40 | 24,258.80 | 427.81 | 1.80% |
| Dow JONES (US) | 46,604.17 | 413.56 | 0.90% |
| FTSE 100 | 9,403.57 | 49.00 | 0.52% |
| HKSE | 25,858.83 | 611.73 | 2.42% |
| NASDAQ | 22,983.42 | 303.45 | 1.34% |
| Nikkei 225 | 49,185.50 | 1,603.35 | 3.37% |
| NZX 50 Index | 13,344.96 | 55.75 | 0.42% |
| S&P 500 | 6,728.38 | 64.37 | 0.97% |
| S&P/ASX 200 | 9,031.90 | 43.70 | 0.49% |
| SSE Composite Index | 3,863.89 | 24.14 | 0.63% |